Skip to menu Skip to content Skip to footer

Chemi-biology computational platform for lead discovery in infectious disease (2012-2014)

Abstract

The proposed computational platform brings together complementary expertise in infectious disease research and advanced computational methods to accelerate the drug discovery process. The use of the Platform will increase the likelihood of discovering successful lead compounds for anti-infective medicine. This Platform, unique in Australia, will consist of high-performance computational hardware and an integrated suite of open source and commercial software linked to curated chemical and biological datasets. The Platform will offer an environment for collaborative research, enabling the sharing of workflows and analytical tools tailored for pre-competitive lead compound discovery in infectious diseases.

Experts

Professor Rob Capon

Affiliate of ARC COE for Innovation
ARC Centre of Excellence for Innovations in Peptide and Protein Science
Institute for Molecular Bioscience
Professorial Research Fellow - GL
Institute for Molecular Bioscience
Affiliate Professorial Res Fellow
School of Chemistry and Molecular Biosciences
Faculty of Science
Rob Capon
Rob Capon